Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial

P. Lorigan; R. Booton; L. Ashcroft; K. O'Byrne; H. Anderson; M. Nicolson; P. A. Burt; C. Faivre-Finn; N. Thatcher

doi:10.1200/jco.2004.22.90140.7066

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial

P. Lorigan
, R. Booton
, L. Ashcroft
, K. O'Byrne
, H. Anderson
, M. Nicolson
, P. A. Burt
, C. Faivre-Finn
, N. Thatcher

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Abstract

Abstracts for the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans,LA, 5‐8 June, 2004 [Abstract No. 7066]

Original language	English
Pages (from-to)	7066-7066
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	22
Issue number	14_suppl
DOIs	https://doi.org/10.1200/jco.2004.22.90140.7066
Publication status	Published - 15 Jul 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/jco.2004.22.90140.7066

Cite this

Lorigan, P., Booton, R., Ashcroft, L., O'Byrne, K., Anderson, H., Nicolson, M., Burt, P. A., Faivre-Finn, C., & Thatcher, N. (2004). Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial. Journal of Clinical Oncology, 22(14_suppl), 7066-7066. https://doi.org/10.1200/jco.2004.22.90140.7066

@article{186acc7b5e5e4e53ad113f34e64503eb,

title = "Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial",

abstract = "Abstracts for the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans,LA, 5‐8 June, 2004 [Abstract No. 7066]",

author = "P. Lorigan and R. Booton and L. Ashcroft and K. O'Byrne and H. Anderson and M. Nicolson and Burt, \{P. A.\} and C. Faivre-Finn and N. Thatcher",

year = "2004",

month = jul,

day = "15",

doi = "10.1200/jco.2004.22.90140.7066",

language = "English",

volume = "22",

pages = "7066--7066",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "14\_suppl",

}

Lorigan, P, Booton, R, Ashcroft, L, O'Byrne, K, Anderson, H, Nicolson, M, Burt, PA, Faivre-Finn, C & Thatcher, N 2004, 'Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial', Journal of Clinical Oncology, vol. 22, no. 14_suppl, pp. 7066-7066. https://doi.org/10.1200/jco.2004.22.90140.7066

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial. / Lorigan, P.; Booton, R.; Ashcroft, L. et al.
In: Journal of Clinical Oncology, Vol. 22, No. 14_suppl, 15.07.2004, p. 7066-7066.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC)

T2 - final results of a British Thoracic Oncology Group (BTOG) trial

AU - Lorigan, P.

AU - Booton, R.

AU - Ashcroft, L.

AU - O'Byrne, K.

AU - Anderson, H.

AU - Nicolson, M.

AU - Burt, P. A.

AU - Faivre-Finn, C.

AU - Thatcher, N.

PY - 2004/7/15

Y1 - 2004/7/15

N2 - Abstracts for the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans,LA, 5‐8 June, 2004 [Abstract No. 7066]

AB - Abstracts for the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans,LA, 5‐8 June, 2004 [Abstract No. 7066]

UR - http://www.mendeley.com/research/randomised-phase-iii-trial-docetaxelcarboplatin-vs-micmvp-chemotherapy-advanced-nonsmall-cell-lung-c

U2 - 10.1200/jco.2004.22.90140.7066

DO - 10.1200/jco.2004.22.90140.7066

M3 - Article

SN - 0732-183X

VL - 22

SP - 7066

EP - 7066

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14_suppl

ER -

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC): final results of a British Thoracic Oncology Group (BTOG) trial

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this